For patients with chronic or complex medical conditions, frequent trips to the hospital or infusion center can be disruptive, stressful and time-consuming.
BrightStar Care® nurses deliver infusions in the home, ensuring treatments are accurate, closely monitored and aligned with treatment protocols.
Our workforce solution provides in-home infusion services for immunotherapy (IvIG), biologics, chemotherapy, total parenteral nutrition, factor and inotropes t. This helps health systems reduce costs, support on-site teams, and enhance patient satisfaction.
As demand for flexible, patient-centered care grows, understanding the value of home infusion is critical.
The Expanding Need for Home Infusion
Growth in Infusion Demand Across Conditions
In-home infusion therapy is quickly becoming a gold standard for treating complex conditions like cancer, endocarditis, congestive heart failure, Crohn’s disease, Lupus, multiple sclerosis and more, offering patients a safe and cost-effective alternative.
According to a September 2025 report in Fortune Business Insights, the global home infusion therapy market is expected to grow by more than 130 percent, rising from approximately $40 billion in 2024 to over $92 billion by 2032. North America led the market in 2023, accounting for 41.78 percent of global revenue. This growth is driven by the rising prevalence of chronic diseases, a growing aging population and the increasing incidence of hospital-acquired infections (HAIs).
The rising demand for flexible care options, like in-home infusion therapy, is further driven by advances in treatment protocols and remote monitoring technologies, which make home care safer and more effective.
The combination of rising patient demand, medical complexity and emerging technologies ensures that home infusion will continue to grow in the months and years ahead.
Why Home Infusion Matters
Many people with chronic diseases rely on friends, loved ones or public transportation to travel to hospitals or outpatient facilities for care. In-home infusion services reduce travel burdens and lower the risk of infection for these vulnerable populations.
One-to-one skilled improves treatment adherence, patient outcomes and quality of life. Treatment adherence and continuity of care is very similar.
Therapies Infusion Nurses Deliver at Home
BrightStar Care infusion nurses are specially trained to provide a broad range of infusion therapies at home and ensure all patients receive convenient, accurate care under the close supervision of registered nurses.
This approach reduces hospital visits and improves overall quality of life.
Our nurses are specially trained to manage side effects, ensure proper dosing and provide patient education tailored to unique needs. They also collaborate with physicians and caregivers, maintaining continuity of care and supporting patients through complex treatments.
Oncology Infusions
Chemotherapy, Immunomodulatory, and immunotherapy require precision and continuous monitoring. BrightStar Care nurses deliver these complex, life-saving treatments at home, helping patients avoid the physical and emotional stress of hospital trips. Oncology infusion at home also lowers the risk of exposure to infections while allowing patients to receive care in a comfortable, familiar environment.
Anti-infective Therapies
IV antibiotic therapy is often required for chronic or complex infections such as osteomyelitis, endocarditis and cellulitis. Our nurses are ready to administer these anti-infective therapies at home, maintain treatment adherence, monitor for adverse reactions and lower the risk of HAIs. By providing this type of care in a home setting, patients experience fewer interruptions and delays to their daily routines while receiving high-quality, compassionate treatment.
Cardiac Therapies
Patients with conditions like congestive heart failure or arrhythmias may require Inotropes, IV diuretics or antiarrhythmic support. Our home infusion nurse support monitors fluid balance, heart rhythms and vital signs to enable timely interventions, improve health outcomes and reduce hospital readmissions. This personalized attention helps patients manage symptoms more effectively and maintain stability between primary care visits.
Nutrition Support (TPN/Enteral Therapy)
Total parenteral nutrition (TPN) or enteral therapy helps patients maintain adequate nutrition and manage comorbidities. Our skilled nurses administer IV nutrition therapy, monitor lab values (e.g., blood glucose, electrolytes, triglycerides, complete blood count), and provide patient and caregiver guidance as needed.
Autoimmune Therapies
Specialty infusion services, like IVIG/SCIG for primary immunodeficiencies, biologics for rheumatoid arthritis, Crohn’s disease and multiple sclerosis (MS), require careful monitoring to manage side effects. Nurses provide tailored support, keeping patients on schedule and adjusting care when needed to ensure optimal outcomes.
BrightStar Care’s workforce solution combines clinical expertise, patient-first in-home care and strict safety protocols. By delivering these complex therapies at home, our nurses help patients achieve better outcomes and greater comfort while reducing the need for hospital- and facility-based care.
Benefits for Patients and Health Systems
Home infusion therapy improves patient outcomes while reducing costs for patients, health systems and payors.
Patients receive personalized care with greater comfort, convenience and treatment adherence. And payors and providers see measurable savings from fewer emergency department (ED) visits and lower overall hospital and outpatient facility fees.
Better Quality of Life for Patients
In-home infusion care offers:
- Enhanced comfort and emotional well-being
- Increased convenience and independence
- Higher satisfaction scores and adherence rates
- Faster recovery and better outcomes
- Lower risk of HAIs, complications and hospital readmissions
- Reduced costs compared with hospital- or facility-based care
According to the National Library of Medicine, “patients overwhelmingly preferred in-home infusion therapy, reporting significantly better physical and mental well-being and less disruption of family and personal responsibilities. Home infusion costs were significantly lower than medical setting costs, with savings between $1,928 and $2974 per treatment course.”
Reduced Costs and Resource Burden for Health Systems
Home infusion therapy for long-term treatments also lowers expenses and resource burden for health systems. Here’s how:
- 26 percent fewer ED visits, according to a systematic review and meta-analysis published in JAMA Network
- 33 to 52 percent lower monthly facility fees and overhead associated with inpatient stays, based on an analysis from UnitedHealth Group
- Lower daily and per-treatment costs result in consistent cost savings for payors. According to the National Home Infusion Association, a Medicare model estimated $3 billion in savings over five years with a home infusion anti-infective therapy benefit
Evidence-Based Outcomes
Home infusion therapy is a clinically effective alternative to inpatient care that is proven to lead to measurable cost savings, improved outcomes and better patient satisfaction.
Studies Across Multiple Conditions
- Safety and Efficacy: A review of multiple studies found that patients receiving infusion therapy at home were no more likely to have adverse side effects or complications than those being treated in a hospital- or facility-based setting. According to an article published in the National Library of Medicine, people with hemophilia had a “40 percent lower chance of being hospitalized from bleeding complications when treated at home.” This statistic also demonstrates how in-home infusion therapy can save on cost savings with a reduction of hospital re-admits and ER visits.
- Cost Savings: According to an analysis from UnitedHealth Group, administering specialty drugs in patients’ homes instead of hospital- or facility-based settings “reduces the cost of drugs and their administration by $16,000 to $37,000 per privately held insured patient per year for five conditions (e.g., multiple sclerosis, immune deficiency, rheumatoid arthritis, inflammatory bowel disease and cancer chemotherapy) that account for 75 percent of spending on administered drugs.
- Improved Patient Outcomes and Satisfaction: Data from the National Home Infusion Foundation (NHIF) Patient Satisfaction Survey indicates that 95 to 97 percent of home infusion patients are “extremely satisfied with their overall patient experience.”
Partner with BrightStar Care
Our workforce solution delivers safe, reliable and personalized in-home infusion care for patients across all conditions.
Our experienced teams are specially trained to ensure your patients receive accurate dosing, close monitoring and guidance as needed to support treatment adherence.
By bringing infusion care home, we also reduce exposure to HAIs, minimize disruptions, and help health systems and payors save time, workforce resources and money.
We invite health systems, Medicare Advantage (MA) plans and specialty pharmacies to partner with us for streamlined care delivery. Our collaborative approach extends the reach of your on-site clinical teams with a highly skilled nursing workforce, allowing you to manage complex cases at a lower cost.
Partnering with BrightStar Care can help your organization improve patient satisfaction scores, reduce emergency room visits and hospital readmissions and maintain the highest level of care.
Supporting Health Systems, Payors and Provider Networks
Our nationwide nurse network spans 41 states and continues to grow. With skilled nursing support in infusion care, we have the infrastructure, clinical expertise and rapid response capabilities you need to support a broad range of medical needs.
We offer:
- Nationwide infusion services across the country.
- Integration with existing workflows and EHRs.
- Infusion Nursing Society-aligned protocols for safety and consistency.
- Rapid referral-to-start times and 24/7 coverage.
- Dedicated account management and ongoing collaboration.
Contact us to learn how we can help you meet the demand for in-home IV therapy.